Beijing Strong Biotechnologies (SZSE:300406) 3-Year EBITDA Growth Rate : 52.80% (As of Sep. 2024)

View and export this data going back to 2014. Start your Free Trial

What is Beijing Strong Biotechnologies 3-Year EBITDA Growth Rate?

Beijing Strong Biotechnologies's EBITDA per Share for the three months ended in Sep. 2024 was ¥0.25.

During the past 12 months, Beijing Strong Biotechnologies's average EBITDA Per Share Growth Rate was 7.10% per year. During the past 3 years, the average EBITDA Per Share Growth Rate was 52.80% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was 12.90% per year. During the past 10 years, the average EBITDA Per Share Growth Rate was 1.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of Beijing Strong Biotechnologies was 60.10% per year. The lowest was -21.70% per year. And the median was 7.30% per year.

Competitive Comparison of Beijing Strong Biotechnologies's 3-Year EBITDA Growth Rate

For the Diagnostics & Research subindustry, Beijing Strong Biotechnologies's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Beijing Strong Biotechnologies's 3-Year EBITDA Growth Rate Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Beijing Strong Biotechnologies's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Beijing Strong Biotechnologies's 3-Year EBITDA Growth Rate falls into.

Beijing Strong Biotechnologies 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

Beijing Strong Biotechnologies (SZSE:300406) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

Beijing Strong Biotechnologies 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Beijing Strong Biotechnologies's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Beijing Strong Biotechnologies Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Beijing Strong Biotechnologies Inc (SZSE:300406) » Definitions » 3-Year EBITDA Growth Rate

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 15 Hua Yuan Dong Lu, 5th Floor, Kuang Yi Building, Haidian District, Beijing, CHN, 100191

Website

http://www.bsbe.com.cn

Beijing Strong Biotechnologies Inc is a China-based provider of in-vitro (IVD) diagnostics products and service. The company is engaged in the research, development, production, and sale of IVD products. It also provides diversified clinical diagnosis solutions to customers. Its products include clinical biochemistry testing, coagulation testing, blood typing, serology and automated blood grouping analyzer. The firm has established a clinical biochemistry platform of the enzymatic method (including enzymatic cycling method), immunoturbidimetric method, and latex immunoturbidimetric method.

Executives

Shuang He	Executives
Luo Ai Ping	Director
	Directors, executives
Liu Wei	Executives
Zhou Ming	Executives
Zhuang Xian Min	Directors, executives
Zhang Yi	Executives
Liu Xi	Directors, executives
Sun Xiao Lin	Director
Yu Jian Ping	Executives

Beijing Strong Biotechnologies Headlines

No Headlines